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Hyperhomocysteinemia causes ER stress and impaired
autophagy that is reversed by Vitamin B
supplementation
Madhulika Tripathi*,1,2,3, Cheng Wu Zhang3, Brijesh Kumar Singh1, Rohit Anthony Sinha1, Kyaw Thu Moe4, Deidre Anne DeSilva*,2,3 and
Paul Michael Yen*,1
Hyperhomocysteinemia (HHcy) is a well-known risk factor for stroke; however, its underlying molecular mechanism remains
unclear. Using both mouse and cell culture models, we have provided evidence that impairment of autophagy has a central role in
HHcy-induced cellular injury in the mouse brain. We observed accumulation of LC3B-II and p62 that was associated with increased
MTOR signaling in human and mouse primary astrocyte cell cultures as well as a diet-induced mouse model of HHcy, HHcy
decreased lysosomal membrane protein LAMP2, vacuolar ATPase (ATP6V0A2), and protease cathepsin D, suggesting that
lysosomal dysfunction also contributed to the autophagic defect. Moreover, HHcy increased unfolded protein response.
Interestingly, Vitamin B supplementation restored autophagic flux, alleviated ER stress, and reversed lysosomal dysfunction due
to HHCy. Furthermore, the autophagy inducer, rapamycin was able to relieve ER stress and reverse lysosomal dysfunction caused
by HHcy in vitro. Inhibition of autophagy by HHcy exacerbated cellular injury during oxygen and glucose deprivation and
reperfusion (OGD/R), and oxidative stress. These effects were prevented by Vitamin B co-treatment, suggesting that it may be
helpful in relieving detrimental effects of HHcy in ischemia/reperfusion or oxidative stress. Collectively, these findings show that
Vitamin B therapy can reverse defects in cellular autophagy and ER stress due to HHcy; and thus may be a potential treatment to
reduce ischemic damage caused by stroke in patients with HHcy.
Cell Death and Disease (2016) 7, e2513; doi:10.1038/cddis.2016.374; published online 8 December 2016
Hyperhomocysteinemia (HHcy) is a clinical condition char-
acterized by increased levels of total plasma homocysteine
(Hcy) and carries an increased risk for stroke.1 Hcy is a
methionine precursor and a sulphur amino acid intermediate in
the methylation and trans-sulfuration pathways. There are
three major dietary cofactors in Hcy metabolism: Vitamin B6,
B12, and folate. Deficiencies in these vitamins were more
prevalent in the developing countries and may account for the
increased incidence of HHcy and stroke found in those
countries.2 Additionally, decreased folate, Vitamin B6, and
Vitamin B12 plasma levels were associated with HHcy;
3
moreover, Vitamin B therapy reduced both Hcy levels and
stroke risk.4,5 HHcy is frequently categorized into three
categories: moderate (plasma Hcy concentrations of
15–30 μmol/l), intermediate (plasma Hcy concentrations of
31–100 μmol/l), and severe (plasma Hcy concentrations
100 μmol/l).6
Autophagy degrades nonfunctional misfolded proteins in
endoplasmic reticulum (ER) to reduce ER stress and
counteract the unfolded protein response.7,8 PERK, IRE1,
and increased cytosolic calcium are potential mediators
of ER stress-induced autophagy in mammalian cells.9
Autophagy decreased ER-mediated apoptosis and cell death,
and thus may have had a cyto-protective effect against ER
stress and nfolded protein response.10 In this regard, HHcy
has been shown to induce ER stress in hepatocytes,
endothelial cells, and vascular smooth muscle,11 but its
effects on autophagy and the brain have not been studied
previously.
The relationship(s) between ER stress and autophagy in
HHcy is not well understood. HHcy increased the risk for
stroke and caused endothelial cell dysfunction, while Vitamin
B supplementation can ameliorate these effects in HHcy.12
However, it was not known whether Vitamin B therapy
stimulated autophagy and/or decreased ER stress in HHcy.
Recent reports have suggested that autophagy may confer
neuroprotection in ischemic brain.13,14 Thus, better
understanding of these processes could lead to new
strategies for neuro-prevention and restoration, reduction of
stroke damage, and prevention of stroke. In this study,
we used mouse brain and primary human/mouse astrocytes
models to show that HHcy inhibited autophagy and was
associated with increased MTOR-lysosomal signaling.
HHcy also increased nfolded protein response and
ER stress. Interestingly, Vitamin B supplementation of the
diet or culture medium after HHcy treatment decreased
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MTOR signaling, which in turn restored autophagy and
reactivated the lysosomal pathway. The MTOR inhibitor,
rapamycin, mimicked the reversal of Hcy-induced inhibition
of autophagy and ER stress. It also counter-acted
HHcy-exacerbated damage caused by reactive oxygen
species, glucose deprivation and reperfusion (OGD/R) in
primary astrocyte cultures.Our findings suggest that Vitamin B
supplementation may provide neuroprotection in HHcy,
and thereby reduce the risk and extent of stroke in patients
with this condition.
Results
Hcy treatment impaired autophagy in primary astrocytes.
Autophagy is a key mechanism for neuronal survival and
functional recovery after stroke.15 To examine the effect of
HHcy on autophagy, we treated primary mouse astrocytes
with varying concentrations of Hcy (0–2 mM) and at different
time points. Western blot results revealed that HHcy caused
significant increases in the levels of autophagy protein LC3B-
II (MAP1LC3B-II) and its adaptor protein SQSTM1/p62 in a
Figure 1 Hcy inhibited autophagy in primary mouse astrocytes. Primary astrocytes were isolated and cultured as described in materials and methods. (a) western blot
analysis of primary mouse astrocytes treated with different Hcy concentrations as mentioned in the figure panel for 48 h. (b and c) Quantitative analysis of MAP1LC3B-II and
SQSTM1, respectively, was done and plotted as bar graphs. (d) Western blot analysis of primary mouse astrocytes treated with 2.0 mM Hcy for different time points as mentioned
in the figure panel. (e and f) Quantitative analysis of MAP1LC3B-II and SQSTM1, respectively was done and plotted as bar graphs. (g) Autophagic flux analysis was done by using
Bafilomycine A1 (50 nM for 6 h) along with or without Hcy (2.0 mM for 48 h). (h) Quantitative analysis of MAP1LC3B-II was done and plotted as bar graphs. The data are shown
as Mean±S.D. and statistical difference *Po0.05 was considered as significant
Figure 2 Hcy increased MTOR signaling and inhibited lysosomal pathway in primary mouse astrocytes. Primary astrocytes were isolated and cultured as described in
materials and methods. (a) Western blot analysis of primary mouse astrocytes treated with different Hcy concentrations as mentioned in the figure panel for 48 h. (b) Quantitative
analysis of phospho-MTOR, RPS6KB1 and EIF4EBP1 proteins was done and plotted as bar graphs. (c) Western blot analysis of primary mouse astrocytes treated with 2.0 mM
Hcy for different time points as mentioned in the figure panel. (d) Quantitative analysis of phospho-MTOR, RPS6KB1 and EIF4EBP1 proteins was done and plotted as bar graphs.
(e) Primary mouse astrocytes treated with Hcy (2.0 mM for 48 h), RT-qPCR analysis of key lysosomal and autophagic genes was performed and plotted as bar graph. (f) Western
blot analysis of primary mouse astrocytes treated with Hcy (2.0 mM for 48 h). (g) Quantitative analysis of western blots in f was done and plotted as bar graphs. The data are
shown as Mean± S.D. and statistical difference *Po0.05 was considered as significant
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dose- (Figures 1a–c) and time- (Figures 1d–f) dependent
manner. Next, we performed autophagic flux analysis using
the lysosomal inhibitor BafA116 and observed a decrease in
autophagic flux by Hcy compared with control samples
(Figures 1g and h). Hcy treatment also increased LC3B-II
and SQSTM1/p62 levels in a dose-dependent manner in
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SH-SY5Y human neuroblastoma cells (Supplementary
Figure 1A–C).
Autophagic flux inhibited by Hcy due to increased MTOR
signaling and lysosomal dysfunction. We observed sig-
nificant dose- and time-dependent increases in the phos-
phorylation of MTOR and its downstream substrates
RPS6KB1/p70S6K and EIF4EBP1 (Figures 2a–d) in primary
astrocytes. Significant increases in levels of MTOR phos-
phorylation downstream substrates RPS6KB1/p70S6K and
EIF4EBP1 could be measured after 24 h treatment
(Figures 2c and d). Similarly, Hcy treatment caused sig-
nificant increases in the level of MTOR phosphorylation and
its downstream substrates RPS6KB1/p70S6K and
EIF4EBP1 in human neuroblastoma SH-SY5Y cells
(Supplementary Figures 2A and B).
Transcription factor EB (TFEB) regulates the expression of
lysosomal and autophagic target genes. MTOR can decrease
lysosomal function by phosphorylating TFEB to cause
cytoplasmic retention and reduce lysosomal gene
expression.17 We observed that Hcy treatment increased
TFEB cytoplasmic retention (Supplementary Figure 2C) and
downregulated the expression of lysosomal and autophagy-
related target genes under the control of TFEB (Figure 2e). In
particular, Hcy treatment decreased LAMP2 and cathepsin D
(CTSD) as well as LC3B, ATG7 and ATG12 gene expression.
Furthermore, lysosomal function was impaired by Hcy, as
protein expression of the membrane-associated lysosomal
protein 2 (LAMP2), vacuolar ATPase (ATP6V0A2), and CTSD
were significantly downregulated (Figures 2f and g). These
results suggested that Hcy impaired autophagic flux by
increasing MTOR signaling and reducing lysosome gene
expression.
Hcy caused endoplasmic reticulum (ER) stress. Since
autophagy is an essential protective mechanism during ER
stress,18 we investigated the effect of Hcy on ER stress. We
observed that Hcy caused dose- (Figures 3a and b) and time-
(Figures 3c and d) dependent increases in the levels of ER
stress marker proteins in mouse primary astrocytes. One of
the most characterized ER chaperones is the 78 kDa
glucose-regulated protein (GRP78), also referred to as BiP.
Hcy increased GRP78 in a dose- and time-dependent
manner. We also observed significant induction of the ER
stress-associated proapoptotic marker CHOP, and phosphor-
ylation of EIF2a and inositol-requiring enzyme-1 (IRE1).
Furthermore, important ER stress response transducers,
activating transcription factor 6 (ATF6), and activating
transcription factor 4 (ATF4) were upregulated by Hcy
treatment in primary mouse astrocytes. We performed similar
studies in the SH-SY5Y human neuroblastoma cells, and
observed a similar dose-dependent increase in ER stress
marker levels (Supplementary Figure 3). Hcy also increased
HERPUD-1 XBP-1s, CHOP, ATF6, and ATF4 mRNA expres-
sion (Figure 3e). These data suggested that inhibition of
autophagy by Hcy was associated with increased ER stress.
Vitamin B12 and folate co-treatment with Hcy induced
autophagy and alleviated lysosomal dysfunction and ER
stress. Modest Vitamin B supplementation was effective in
reducing elevated plasma Hcy concentrations.19 Therefore,
we next examined the effects of vitamin supplementation
(Vitamin B12+folate) in vitro during Hcy treatment. Primary
mouse and human astrocytes as well as neuroblastoma SH-
SY5Y cells, were co-treated with Hcy (2 mM) as well as
vitamins B12, and folate (5 μM; 1 : 1) for 48 h. Protein levels of
LC3B-II and SQSTM1/p62 were significantly decreased in
the co-treated cells compared with Hcy-treated cells in both
primary mouse (Figures 4a and b) and human astrocytes
(Figures 4c and d). Furthermore, we confirmed autophagic
flux by ectopically expressing tandem fluorescence-LC3B (tf-
LC3B) in SH-SY5Y cells treated with Hcy with or without
Vitamin B12 and folate (Figure 4e). In this assay, RFP tagged
to LC3B detected both autophagosomes and autolysosomes,
whereas eGFP tagged to LC3B detected only autophago-
somes (since eGFP is quenched in acidic pH compartments).
Thus, yellow fluorescence occurred in autophagosomes (in
overlay image) whereas red fluorescent puncta were found in
autolysosomes. This functional assay for autophagy detected
autophagosomes relative to autolysosomes (remaining red
puncta), in merged images, and was a useful method for
characterizing autophagic flux.20 Using this technique, we
observed that Hcy treatment increased yellow puncta,
suggesting accumulation of autophagosomes, whereas
Vitamin B12 and folate co-treatment with Hcy increased
autolysosome (red puncta) formation in merged images,
indicating increased autolysosome formation (Figure 4e).
Moreover, we observed that cells co-treated with Vitamin B12
and folate together with Hcy reduced phosphorylation of
MTOR and its downstream targets RPS6KB1/p70S6K and
EIF4EBP1 compared with cells treated with Hcy alone in
primary mouse (Figures 4f and h) and human (Figures 4g and
i) astrocytes.
We also observed that Vitamin B12 and folate supplementa-
tion contributed to the recovery of lysosomal function. In
particular, Vitamin B12 and folate co-treatment with Hcy
restored LAMP2, vacuolar ATPase (ATP6V0A2), and lysoso-
mal hydrolase CTSD expression in primarymouse (Figures 5a
and b) and human (Figures 5c and d) astrocytes. Vacuolar
ATPase is an ATP-driven proton pump importing protons into
the lysosomal lumen, and is responsible for the acidification of
the lysosome to enable the maturation and activation of
lysosomal enzymes such as CTSD. Thus, maintenance of
acidity is a hallmark of functionally mature lysosomes.
Accordingly, we assessed lysosomal acidification using
acridine orange (AO) staining. SH-SY5Y cells that were co-
treated with Vitamin B12, folate, and Hcy showed a dramatic
increase in orange/red fluorescence compared with Hcy-
treated and control cells (Figures 5e and f), confirming an
increase in the number of functioning acidic compartments
that is, lysosomes, in cells co-treated with these vitamins.
To directly evaluate the effects of Vitamin B12 and folate
supplementation on Hcy-induced ER stress and autophagic
flux, we performed western blot analysis of ER stress markers
GRP78, CHOP, ATF6, and ATF4. Results revealed that ER
stress markers were upregulated in Hcy-treated cells and
reversed by Vitamin B12 and folate co-treatment (H+V) in
primary mouse (Figures 5g and h) and human astrocytes
(Figures 5i and j), respectively. These findings demonstrated a
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protective role for Vitamin B12 and folate against Hcy-induced
ER stress.
The CLEAR (Coordinated Lysosomal Expression and
Regulation) gene network regulated by TFEB is a critical
control point for lysosomal biogenesis and its function.
Previously, it was shown that TFEB regulates the transcription
of target genes closely related to lysosomal structure and
function, including hydrolases, lysosomal membrane proteins,
and the vacuolar ATPase complex.21 We thus performed
RT-qPCR analysis of lysosome (LAMP2 and CTSD) and
autophagy (MAP1LC3B, SQSTM1/p62, ATG5, ATG7,
and ATG12) genes (Figure 5k) in primary human astrocytes.
Figure 3 Hcy increased ER stress in primary mouse astrocytes. Primary astrocytes were isolated and cultured as described in materials and methods. (a) Western blot
analysis of primary mouse astrocytes treated with different Hcy concentrations as mentioned in the figure panel for 48 h. (b) Quantitative analysis of ER stress marker proteins
was done and plotted as bar graphs. (c) Western blot analysis of primary mouse astrocytes treated with 2.0 mM Hcy for different time points as mentioned in the figure panel. (d)
Quantitative analysis of ER stress marker proteins was done and plotted as bar graphs. (e) Primary mouse astrocytes treated with Hcy (2.0 mM for 48 h), RT-qPCR analysis of
key ER stress genes was performed and plotted as bar graph. The data are shown as Mean± S.D. and statistical difference *Po0.05 was considered as significant
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Hcy treatment decreased mRNA expression of these genes,
whereas Vitamin B12 and folate treatment restored their mRNA
expression. Furthermore, Vitamin B12 and folate co-treatment
with Hcy restored mRNA expression of Hcy-responsive
endoplasmic reticulum-resident ubiquitin-like domain member
2 protein (HERPUD-1) and the ER stress genes, XBP-1s,
CHOP, ATF6 and ATF4 (Figure 5k). Collectively, our results
strongly suggested that Vitamin B12 and folate co-treatment
with Hcy was able to prevent lysosomal dysfunction, impair-
ment in autophagic flux, and associated ER stress.
Figure 4 Vitamin B12 and folate prevented Hcy-induced autophagic inhibition. (a and c) Western blot analysis of primary mouse and human astrocytes, respectively treated
with Hcy (2.0 mM for 48 h) alone or along with Vitamin B12 and folate (1 : 1; 2 mM). (b and d) Quantitative analysis of MAP1LC3B-II and SQSTM1 proteins was done and plotted
as bar graphs. The data are shown as Mean± S.D. and statistical difference *Po0.05 was considered as significant. (e) SH-SY5Y neuroclastoma cells were transfected with ptf-
LC3B and treated with Hcy (2.0 mM for 48 h) alone or along with Vitamin B12 and folate (1 : 1; 2 mM). autophagic flux analysis was then performed by analyzing red puncta
formation under confocal microscope at 40 × magnification. Representative micrographs are shown here and enlarged view in the inset. (f and h) Western blot analysis of primary
mouse and human astrocytes, respectively, treated with Hcy (2.0 mM for 48 h) alone or along with Vitamin B12 and folate (1 : 1; 2 mM). (g and i) Quantitative analysis of key
MTOR signaling proteins was done and plotted as bar graphs. The data are shown as Mean± S.D. and statistical difference *Po0.05 was considered as significant
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Increased ER stress correlated with the accumulation of
SQSTM1/p62 and MAP1LC3B-II in vivo using a diet-
induced mouse model of HHcy. To examine the effects of
Vitamin B (B6, B12, and folate) therapy during HHcy in vivo,
we used a dietary approach to induce HHcy in mice
(as described in the Material and Methods) that were divided
into three groups: control, methionine without Vitamin B
(HHcy) (M+B−), and methionine with Vitamin B (M+B+).
Mice fed with M+B− diet showed a significant increase
in Hcy levels compared with controls (plasma total
Hcy= 80.7±19.93 μmol/l versus 7.9± 1.4 μmol/l). The M+B+
diet reversed HHcy in these mice as Hcy levels returned to
Figure 5 Vitamin B12 and folate prevented Hcy-induced decrease in lysosomal pathway. (a and c) Western blot analysis of primary mouse and human astrocytes,
respectively, treated with Hcy (2.0 mM for 48 h) alone or along with Vitamin B12 and folate (1 : 1; 2 mM). (b and d) Quantitative analysis of key lysosomal proteins was done and
plotted as bar graphs. (e) SH-SY5Y neuroclastoma cells were treated with Hcy (2.0 mM for 48 h) alone or along with Vitamin B12 and folate (1 : 1; 2 mM); and stained with AO for
30 min. Acidic compartments (lysosomal vesicles as RED) and nucleus (as GREEN) were observed under fluorescence microscope and captured using LAS software, analyzing
red puncta formation under confocal microscope at 20 × magnification. Representative micrographs are shown here and enlarged view in the inset. (f) Relative fluorescence of
lysosomal vesicles (RED) and nucleus (GREEN) was measured using ImageJ software (NIH, USA) and plotted as bar graph. The data are shown as Mean±S.D. and statistical
difference *Po0.05 was considered as significant. (g and i) Western blot analysis of primary mouse and human astrocytes, respectively, treated with Hcy (2.0 mM for 48 h) alone
or along with Vitamin B12 and folate (1 : 1; 2 mM). (h and j) Quantitative analysis of key lysosomal proteins was done and plotted as bar graphs. (k) Primary human astrocytes
treated with Hcy (2.0 mM for 48 h) alone or along with Vitamin B12 and folate (1 : 1; 2 mM), RT-qPCR analysis of key lysosmal, autophagy and ER stress pathway genes was
performed and plotted as bar graph. The data are shown as Mean± S.D. and statistical difference *Po0.05 was considered as significant
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control levels (plasma total Hcy=8.9± 1.1 μmol/l versus
7.9±1.4 μmol/l).
Western blots of brain tissues from these groups showed
that there was increased accumulation of LC3B-II and
SQSTM1/p62 proteins from brain tissue in mice fed M+B−
(HHcy), confirming the autophagic inhibition observed in the
cell culture studies (Figures 6a–c). Furthermore, we observed
that Diet M+B− caused an increase in MTOR phosphorylation
and its downstream targets RPS6KB1/p70S6K and
EIF4EBP1 (Figures 6d and e). In contrast, there were
significant decreases in the levels of LC3B-II and SQSTM1/
p62 in brain tissue from mice fed with B12, B6 and folate
supplemented diet (M+B+), confirming the induction of
autophagy in these samples. In the brain tissue of mice fed
M+B+. the expression of the phosphorylated MTOR,
RPS6KB1, and EIF4EBP1 was decreased. Mice fed M+B−
had decreased brain expression of the lysosomal proteins,
LAMP2, CTSD, and ATP6V0A2 that was restored to basal
levels in the mice fed M+B+ (Figures 6f and g). Of note, there
were no significant changes in expression of autophagy genes
in vivo (Supplementary Figure 4).
We next examined the expression of ER stress proteins in
the same mouse brain tissues. Diet M+B− increased expres-
sion of ER stress proteins (GRP78, CHOP, ATF6, and ATF4),
and the phosphorylation of IRE1 and eIF2a. In contrast,
Vitamin B-fortified diet (Diet M+B+) was able to rescue this
increase in ER stress marker proteins (Figures 6h and i). We
then examined mRNA expression of genes involved in ER
stress (Figure 6j) and found that HHcy increased mRNA levels
of HERPUD-1 and other ER stress markers, XBP-1 s, ATF6,
ATF4 andCHOP during HHcy treatment that were reversed by
Vitamin B co-treatment.
MTOR inhibitor rapamycin prevented ER stress and
induced autophagy in Hcy-treated primary human astro-
cytes. Our in vitro and in vivo studies showed that HHcy
reduced autophagic flux via stimulation of MTOR signaling
and also increased ER stress; moreover, these effects were
Figure 6 Vitamin supplementation during diet-induced HHcy reversed autophagic block, MTOR signaling activation lysosomal dysfunction and alleviated ER stress in mouse
brain. (a, d, f, and h) Western blot analysis of brain tissue isolated from mouse fed on control diet, diet rich in Methionine and deficient in vitamin supplementation (M+B−) caused
HHcy; and diet rich in methionine as well as 3 × supplemented with vitamin (M+B+). (b and c) Quantitative analysis of MAP1LC3B-II and SQSTM1, respectively, was done and
plotted as bar graphs. (e, g, and i) Quantitative analysis of western blots in d (for MTOR signaling), f (for lysosomal pathway), and i (for ER Stress) are plotted as bar graphs. The
data are shown as Mean±S.E.M. and statistical difference *Po0.05 was considered as significant. (j) RT-qPCR analysis of mouse brain tissues to analyze key genes of
lysosomal pathway and ER stress. The data are shown as Mean± S.E.M. and statistical difference *Po0.05 was considered as significant
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relieved by Vitamin B therapy. We thus investigated whether a
MTOR inhibitor that stimulates autophagy and lysosomal
activity such as rapamycin could also relieve HHcy-
associated ER stress. Rapamycin co-treatment with Hcy in
primary human astrocytes reduced both LC3B-II and
SQSTM1/p62 protein levels when compared with Hcy
treatment alone (Figures 7a and b), confirming induction of
autophagy. We also observed that rapamycin decreased
phosphorylation of MTOR and its downstream targets,
RPS6KB1/p70S6K and EIF4EBP1 (Figures 7c and d).
Additionally, rapamycin co-treatment with Hcy prevented the
ER stress induced by Hcy, as evident by significant
reductions in the levels ER stress markers GRP78, CHOP,
ATF6 and ATF4, and phosphorylation of IRE1 and eIF2a in
Figure 7 MTOR inhibitor rapamycin treatment reversed Hcy-induced ER stress and inhibition in autophagy. (a, c and e) Western blot analysis of primary human astrocytes
treated with Hcy (2.0 mM for 48 h) alone or along with rapamycin (50 μM) for autophagy, MTOR signaling and ER stress, respectively. (b, d and f) Quantitative analysis of western
blots was done and plotted as bar graphs. The data are shown as Mean± S.D. and statistical difference *Po0.05 was considered as significant
Vitamin B supplementation reverses ER stress caused by Hyperhomocysteinemia
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primary human astrocytes treated with Hcy and rapamycin
(Figures 7e and f). These results strongly suggested that
autophagic inhibition by HHcy occurred upstream to ER
stress and was a cause, rather than a consequence, of
increased unfolded protein response.
Hcy treatment decreased cell survival in an oxygen and
glucose deprivation/reperfusion (OGD/R) model and an
oxidative stress model. From the foregoing in vitro and
in vivo results, we hypothesized that higher levels of Hcy not
only had deleterious effects on the cell but also may increase
susceptibility to secondary cellular damage after an insult/
injury such as ischemia/reperfusion during stroke. Accord-
ingly, we used an OGD/R model to mimic cerebral I/R injury
in vitro. We observed a 30% decrease in cell survival after
OGD/R exposure in primary human astrocytes (Figure 8a),
which was further decreased to 46% when cells were
pretreated with Hcy prior to ODG/R exposure. In contrast,
Vitamin B12 and folate supplementation with Hcy increased
cell survival to 95% after OGD/R exposure. Furthermore, the
cellular apoptotic marker poly-(ADP-ribose) polymerase
cleavage (cPARP) also was increased after OGD/R exposure
to primary human astrocytes (Figures 8b and c). Hcy
pretreatment further enhanced OGD/R-induced cPARP,
whereas vitamin supplementation significantly reduced
cPARP expression in Hcy+OGD/R-exposed cells. Oxidative
stress also can increase cell death during ischemia/reperfu-
sion;22 therefore, we used tert-BHP, a short-chain organic
hydroperoxide that contains a tertiary butyl group and a
hydrodioxygen group to induce cell death. This compound
produces free radicals that can oxidize organelles nearby that
lead to oxidative stress.23 tert-BHP co-treatment with Hcy in
primary human astrocytes decreased cell survival and
increased cPARP expression (Supplementary Figures
5A–C). However, vitamin co-treatment with Hcy and
tert-BHP prevented this decrease in cell survival and
decreased cPARP expression. These data strongly
suggested that Hcy treatment further exacerbated the
deleterious effects of OGD/R and oxidative stress. Vitamin
B12 and folate supplementation reduced cell death and
cPARP expression in Hcy-treated cells that were exposed to
both insults.
Discussion
Hcy is a key metabolic intermediate in sulfur-containing amino
acid metabolism. Besides genetic causes of HHcy due to
mutations in Methylene tetrahydrofolate reductase (MTHFR),
HHcy occurs with deficiencies of folate, B6, and B12 that
normally serve as enzyme co-factors in Hcy metabolism.
HHcy is a strong and independent risk factor for vascular
diseases, including ischemic cerebral stroke,24 and serum
levels of Hcy may represent a modifiable risk factor for
stroke.25 For example, it now is widely recognized that B
vitamin therapy reduces Hcy levels and may decrease risk for
stroke.26 Several studies and meta-analyses, including the
HOPE-2 trial, the French SuFolOM3 trial, a subgroup analysis
of the Vitamin Intervention for Stroke Prevention Trial that
excluded patients with renal failure, and a subgroup analysis
of the VITATOPS trial that excluded patients on antiplatelet
therapy, all showed a reduced risk of stroke after vitamin
supplementation.27 Recent studies have suggested that
autophagy also promotes survival during stroke.17 Stress in
the ER compartment of the cell has been implicated in a
variety of neural injury models, including ischemic stroke.28
Currently, the underlying relationships between ER stress,
autophagy, and cell death in the brain during HHcy are not well
understood. Moreover, little is known about the interplay of
these cellular responses to stressors or injury in the brain.
In this study, we showed that HHcy has deleterious effects
on autophagy and ER stress in primary astrocytes and in
brain. Our results revealed that higher Hcy level led to
accumulation of p62 and LC3B-II proteins consistent with a
blockade of autophagy flux (Figures 1a and b; Figures 4a–d;
Figure 8 Hcy treatment increased OGD/R-induced damage in primary human
astrocytes, which was rescued by vitamin co-treatment. (a) Percent cell viability was
analyzed by MTS assay as described in material and methods. OGD/R exposure was
performed as described in material and methods to mimic I/R in vitro. (b) Western blot
analysis of primary human astrocytes treated with Hcy and Hcy+vitamin, exposed to
OGD/R. (c) Quantitative analysis of western blots was done and plotted as bar
graphs. The data are shown as Mean± S.D. and statistical difference *Po0.05 was
considered as significant
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and Figures 6a–c). Moreover, HHcy increased ER stress
(Figures 6f and g). Under physiological conditions, induction of
autophagy serves as a protective mechanism in response to
ER stress. However, our data showed that inhibition of
autophagic flux during HHcy significantly increased expres-
sion of ER stress markers such as CHOP, XBP-1s, ATF6,
ATF4, and GRP78/BIP (Figures 3e and 6j). Of note, GRP78
previously was shown to interact directly with apoptotic
pathway intermediates, block caspase activation, and inhibit
apoptosis and cell death.29 Thus, it is likely that autophagic
inhibition contributes and/or exacerbates ER stress in the
brain. Interestingly, Vitamin B12, B6, and folate supplementa-
tion of the methionine diet for mice with HHcy both induced
autophagy and reduced ER stress markers to basal levels
(Figures 6a–c).
Elevated serum Hcy levels previously were shown to be
associated with impaired autophagy in the brain but the
mechanism was not identified.30 Here we showed that
increased Hcy concentrations in vitro and in vivo impaired
autophagy by stimulating MTOR-lysosomal signaling. MTOR
signaling previously was shown to inhibit autophagosome
formation.31 Although we observed that increased Hcy level
upregulated MTOR signaling (Figures 2a–d; Figures 4h–i; and
Figures 6d–e), Hcy treatment surprisingly increased both
LC3B-II and SQSTM1/p62 expression, suggesting that there
also was a late block in autophagy (Figures 1a–c) occurring
after autophagosome formation, involving either autophag-
some/ lysosome fusion or lysosomal degradation.32
MTOR regulates lysosomal biogenesis and activity by
phosphorylating TFEB and decreasing its nucleo-cytoplasmic
translocation.33 Interestingly, we found that Hcy treatment
increased TFEB cytoplasmic localization presumably due to
TFEB phosphorylation by MTOR (Supplementary Figure 2C).
To further understand autophagy inhibition by Hcy, we
investigated expression of lysosomal proteins and their
functions. Hcy decreased expression of key lysosomal
proteins LAMP2, ATP6V0A2, and CTSD expression in mouse
brain and in primary astrocytes (Figures 6f and g). There also
was decreased lysosomal acidification in astrocytes treated
with Hcy (Figures 6e and f). Our data strongly suggested that
impairment in lysosomal function led to the accumulation of
autophagic proteins, LC3B-II and SQSTM1/p62. Furthermore,
the decreased LAMP2 (membrane protein) and CTSD protein
levels in HHcy suggested a decrease in the number of
lysosomes and/or insufficient autophagosome/lysosomal
fusion. The decrease in vacuolar ATPase (ATP6V0A2)
expression by Hcy likely reduced lysosomal acidification.
Interestingly, Vitamin B supplementation in vitro (B12 and
folate) and in vivo (B6, B12, and folate) significantly reversed
HHcy-induced changes in MTOR signaling and lysosome
formation/function (Figures 6d–g). Taken together, these
findings showed that Hcy inhibited autophagy by upregulating
MTOR signaling and inhibiting the lysosomal pathway, and
these effects caused by HHcy could be reversed by Vitamin B
supplementation.
Rapamycin is a FDA-approved immunosuppressant and
MTOR inhibitor that is widely used during organ transplanta-
tion. It has been reported to reduce injuries in several models
of neurodegenerative disorders by inducingMTOR-dependent
autophagy.34 Sheng et al. also demonstrated neuroprotection
properties of rapamycin in rat focal cerebral ischemia
preconditioning.35 Moreover, it has been reported that
rapamycin provided neuroprotection in a neonatal-hypoxia-
ischemia model by activating autophagy and inhibiting
apoptosis.36 Interestingly, we found that rapamycin reversed
the autophagic inhibition and ER stress in primary mouse
astrocytes-treated HHcy (Figures 7a–f).
Hcy levels are associated with secondary vascular events
and mortality after stroke.27 We thus examined the effect of
Vitamin B supplementation (B12 and folate) on cell viability
after exposure of stress in cells treated with Hcy. Primary
human astrocytes treated with Hcy and preconditioned by
OGD/R or oxidative stress had increased cell death
(Figures 8a–f). Vitamin B12, folate co-treatment with Hcy
significantly reduced the harmful effects of OGD/R and
oxidative stress, and improved cell survival. These findings
suggest that it is possible that Vitamin B therapy may reduce
cell death after exposure to a major stressor such as stroke.
Our findings may have clinical implications as therapies
aimed to restore the autophagic flux in patientswith HHcy, may
prevent stroke and or reduce neuronal damage after a stroke.
Vitamin B therapy reduced ER stress and cell death in mouse
brain and primary astrocytes and neuroblastoma cells during
HHcy. Since vitamins restored lysosomal function and
autophagy flux during HHcy (Supplementary Figure 6), it is
possible that drugs that have effects on these pathways may
have similar beneficial effects. Indeed, we found that
rapamycin was able to restore autophagy and reduce ER
stress in primary astrocytes treated with Hcy. Thus, drugs that
enhance autophagy and lysosomal functionmay be potentially
useful for the prevention and treatment(s) for stroke in patients
with HHcy.
Material and Methods
Drugs and reagents. D,L-Homocysteine, Vitamin B12, Folate, Luperox
TBH70X (tert-Butyl hydroperoxide solution), Rapamycin and Acridine Orange
(AO) were purchased from Sigma-Aldrich (MO, USA). Antibodies were procured
from Cell Signaling Technologies (Danvers, MA, USA) (LC3B, 2775; SQSTM1/p62,
5114; MTOR (7C10) rabbit mAb, 2983; phospho-MTOR (Ser2448) (D9C2),
p-eIf2alpha, 9722 S; RPS6KB1/p70S6 kinase (49D7) rabbit mAb, 2708; phospho-
RPS6KB1/p70S6 kinase (Thr389) (108D2) rabbit mAb, 9234; GAPDH (D16H11);
ATF6 (70B1413.1, mouse Ab, Novus Biologicals, Littleton, CO, USA), NBP1-40256;
p-IRE1alpha, rabbit Ab, NB100-2323; IRE1alpha rabbit Ab, (14C10), 3294P, Novus
Biologicals; ATP6V0A2, ab96803, rabbit Ab, Abcam (Cambridge, MA, USA); CHOP
(L63F7) mouse Ab, 2895 S; Cleaved PARP (D214), rabbit Ab, 9544P; LAMP2
(CD107b) rabbit Ab, Thermo Fisher Scientific Inc., CA, USA; Xbp-1s, (M-186), sc-
7160, rabbit Ab; Bip-GRP78, (C50B12), rabbit Ab; Anti-CTSD (SAB2106553), rabbit
Ab. Culture media and transfection reagents were from Invitrogen, Thermo Fisher
Scientific Inc., CA, USA. ptfLC3 (Plasmid No. 21074) was procured from Addgene
(Cambridge, MA, USA) and TFEB plasmid (Plasmid No. 38119) was also procured
from Addgene, SHY transfection (DNA-In® SY5Y, GST-2151) reagent was procured
from MTI-Globalsystem.com (Thermo Fisher Scientific Inc.), S-adenosyl methionine
(SAM) (CEG414Ge) kit was procured from Cloud clone Corp (Houston, USA).
HHCy diet was customized by Harlan Teklad, Madison, WI, USA.
Animal maintenance and diet-induced hyperhomocysteinimia
mice model. Male C57BL/6 mice (8- to 10-wk-old) were purchased and
housed in hanging polycarbonate cages under a 12 h/12 h light/dark schedule.
Animals were killed in CO2 chambers. All mice were maintained according to the
Guide for the Care and Use of Laboratory Animals (NIH publication no. One.0.0.
Revised 2011), and experiments were approved by the IACUCs at Singhealth
(2013/SHS/848).
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Dietary approach was used to generate the HHcy mouse model.37 Diet was
customized by Harlan Teklad. Mice (n= 32) were randomized and divided in two
groups, group I (n= 16) received control diet (AIN-93M), whereas group II (n= 16)
received diet rich in Methionine and deficient in vitamin supplementation (M+B− ),
which induced HHcy. After 12 weeks, 8 mice from each group was killed and Hcy level
was measured in plasma. Remaining mice from group II, now considered as group III,
were put on diet rich in methionine and 3X supplemented with vitamin (M+B+) for
12 weeks. Once confirmed as HHcy model, mice were killed and whole brain was
taken out and freezed in liquid nitrogen for further total RNA and protein isolation.
Their serum Hcy was measured at every 4-week interval for 24 weeks
(Supplementary Figure 7). For blood serum Hcy measurement, blood was collected
by submandibular bleeding.38 We have also measured their s-adenosyl methionine
(SAM)/s-adenosyl homocysteine (SAH) ratio (Supplementary Table 1).
All the diets contained 1% sulfathiozole (10 g/kg, Sigma-Aldrich, MO, USA), a
nonabsorbed sulpha drug to inhibit folate formation by gut bacteria just to ensure that
the animal’s only source of available folate is from diet.
Homocysteine detection. Mouse Homocysteine Kit (Crystal Chem, Chi-
cago, IL, USA Catalog No.80440): Homocysteine was evaluated in mouse serum
according to manufacturer’s protocol.
Cell culture and maintenance
Primary mouse astrocytes: Mouse pups postnatal 1–3 days were anesthe-
tized and decapitated. The brain is dissected in cold PBS under microscope. After
the olfactory bulb and hippocampus removed, the cortex is collected and then
trypsinized for 30 min at room temperature. After trypsinization, the cortex is
washed with glia cell culture medium (Gibco, Thermo Fisher Scientific Inc.) for 3
times and is then triturated with 2 ml pipette till no chunks are observed. The glia
cells are collected by centrifuge 1000 × g for 5 min. The supernatant is removed and
the cells are suspended and seeded in Poly-D-Lysine coated T75 flask. After 1 week
culturing in 37 °C incubator with 5% CO2, the T75, the cells get confluent. Then the
T75 flask is moved onto an orbital shaker and shaked for 200 r.p.m overnight to
remove the microglias and oligodentrocytes. The purity of primary astrocytes were
confirmed by GAFP (astrocyte-specific marker) staining. Purified astrocytes were
then collected for experiment and maintained in astrocytes culture medium that was
DMEM-supplemented with 15% fetal bovine serum, 1% Penicillin/Streptomycin,
2 mM L-glutamine, 0.1 mM nonessential amino acids.
Primary human astrocytes: Primary human astrocytes were purchased from
Lonza (Clonetics, Lonza, Walkersville, MD, USA) Normal Human Astrocytes (NHA).
These cells were cultured and maintained using astrocytes growth medium bullet kit
(AGM Bullet kit: CC-3187 & CC-4123) containing astrocytes basal medium, growth
factors, cytokines and required supplements, as per manufacturer’s description.
SH-SY5Y neuroblastoma cell culture: SH-SY5Y, a human-derived neuro-
blastoma cell line, was procured from ATCC (Manassas, VA, USA) (ATCC
CRL-2266). SH-SY5Y cells are often used as in vitro models to study diverse
neuronal function in neurobiology.39 SH-SY5Y cells were cultured with complete
medium (DMEM with 10% fetal bovine serum, 1% Penicillin/Streptomycin) and are
passaged every 3–4 days.
Vitamin treatment: Hcy and Vitamin B12 were dissolved in water whereas Folate
was dissolved in 0.1 M NaOH. Compounds were diluted in culture medium to final
concentration of 2 mM (Hcy) or 5 μM (Vitamin B12 and Folate). For dose-dependent
study, Hcy was serially diluted in culture medium to obtain 0.5, 1.0, and 2.0 mM.
Oxygen and glucose deprivation/reperfusion (OGD/R). To mimic
ischemic-reperfusion like conditions in vitro, cell cultures were exposed to oxygen-
glucose deprivation/reoxygenation (OGD/R).40 This existing model could mimic
extracellular conditions in cerebral ischemia and subsequently reperfusion, and is
commonly used as a model for in vitro research.41 In brief, to induce OGD/R injury,
cultured primary human astrocytes were cultured in 12-well plate. After 90%
confluency, rinsed and incubated in a glucose-free Hank's balanced salt solution
(HBSS) composed of 140 mM NaCl, 1.2 mM MgSO4, 1.7 mM CaCl2, 3.5 mM KCl,
10 mM HEPES, 5 mM NaHCO3, and 0.4 mM KH2PO4 (pH 7.3). Then, the cultures
were placed into a specialized, humidified chamber filled with 95% N2 and 5% CO2
at 37 °C for 6 h. Controls were incubated with the HBSS buffer containing 5.6 mM
glucose in a humidified incubator with 5% CO2 at 37 °C for the same times as the
OGD-R cultures. After the challenge, cultures were transferred to normal culture
medium and returned to normoxic conditions for 12 h to mimic reperfusion. The
indicated concentrations of HHcy and vitamin supplementation was added to the
culture medium 12 h before OGD-R and maintained until the end of recovery.
In vitro transfection and confocal microscopy. Human neuroblastoma
SH-SY5Y cells grown on poly-D-lysine-coated chambered slides till 90% confluency.
ptfLC3 (Plasmid No. 21074) or pEGFP-N1-TFEB (plasmid No. 38119) plasmids
were transfected using DNA-In SY5Y (GST-2151; MTI-GlobalStem) as described in
manufacturer’s protocol. ptfLC3 was a gift from Tamotsu Yoshimori and described
elsewhere,42 whereas pEGFP-N1-TFEB was a gift from Shawn Ferguson.43 After
24 h of transfection, cells were treated with Hcy and/or Vitamin B12+folate for further
48 h. The cells were then fixed with 4% paraformaldehyde for 15 min and washed
three times with PBS. Slides were washed and wet mounted in VECTASHIELD
Antifade Mounting Medium. Fluorescence imaging was performed using LSM710
Carl Zeiss (Carl Zeiss Microscopy GmbH, Oberkochen, Germany) confocal
microscope at 40 × magnification.
Acridine orange (AO) staining. Cells were grown on poly-D-lysine coated
24-well plate and treated with Hcy and/or Vitamin B12+Folate for 48 h. Thereafter,
cells were incubated with either 1 μg/ml of AO (Sigma-Aldrich) in PBS for 30 min at
37 °C, followed by three washes with PBS, and then immediately observed under a
fluorescence microscope.
MTS assay. MTS Cell Proliferation Colorimetric Assay Kit (K300–500) was
procured from Bio Vision (Milpitas, CA, USA) and instructions were followed as
manufacturer’s protocol to obtain results.
Western blot analysis. Cells and tissue samples were lysed using CelLytic M
Cell Lysis Reagent (Sigma, C2978). Proteins samples were prepared in 2 ×
Laemmli Sample Buffer (BioRad No. 1610737, Hercules, CA, USA), separated on
SDS-PAGE and immunoblotted using standard protocol. Densitometric analysis was
performed using ImageJ software (NIH, Bethesda, MD, USA).
RNA isolation and real-time PCR. Total RNA was isolated using Qiazol
(Qiagen, Hilden Germany) and RT-qPCR was performed using the QuantiTect
SYBR Green PCR Kit (Qiagen, 204141) in Rotor-Gene Q (Qiagen) according to the
manufacturer's instructions. Primer details can be provided upon request.
Quantitative and statistical analysis. Results were expressed as
Mean± S.D. (for all in vitro experiments) or S.E.M. (for all in vivo experiments).
The statistical significance of differences *Po0.05 was assessed by one-way
ANOVA followed by Tukey’s post-hoc test using PRISM (Graph Pad) for comparing
the different groups. Student’s t-test was used for comparing control versus treated
groups.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. We acknowledge the funding from A*StaR Translational
Clinical Research Project (BMRC13/1/96/19/691) (PMYand DD), Clinician Scientist
Award (NMRC/CSA/0054/2013) (PMY), and Singhealth Foundation Start-Up Grant
(SHF/FG635S/2014) (MT).
1. Kamat PK, Vacek JC, Kalani A, Tyagi N. Homocysteine Induced cerebrovascular
dysfunction: a link to alzheimer's disease etiology. Open Neurol J 2015; 9: 9–14.
2. Sanchez-Moreno C, Jimenez-Escrig A, Martin A. Stroke: roles of B vitamins, homocysteine
and antioxidants. Nutr Res Rev 2009; 22: 49–67.
3. Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC et al. High prevalence of
hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and
vitamin B-6 status. J Nutr 2007; 137: 407–413.
4. Mudd SH, Finkelstein JD, Refsum H, Ueland PM, Malinow MR, Lentz SR et al.
Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler
Thromb Vasc Biol 2000; 20: 1704–1706.
5. Spence JD. B vitamin therapy for homocysteine: renal function and vitamin B12 determine
cardiovascular outcomes. Clin Chem Lab Med 2013; 51: 633–637.
6. Christopher R, Nagaraja D, Shankar SK. Homocysteine and cerebral stroke in developing
countries. Curr Med Chem 2007; 14: 2393–2401.
Vitamin B supplementation reverses ER stress caused by Hyperhomocysteinemia
M Tripathi et al
12
Cell Death and Disease
7. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S et al. Autophagy is activated
for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006; 26: 9220–9231.
8. Xu Y, Yu H, Qin H, Kang J, Yu C, Zhong J et al. Inhibition of autophagy enhances cisplatin
cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer
Lett 2012; 314: 232–243.
9. Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H et al. ER stress (PERK/eIF2alpha
phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for
autophagy formation. Cell Death Differ 2007; 14: 230–239.
10. Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL et al. ER stress-mediated
autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest 2012;
122: 4621–4634.
11. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY et al. Homocysteine-
induced endoplasmic reticulum stress causes dysregulation of the cholesterol and
triglyceride biosynthetic pathways. J Clin Invest 2001; 107: 1263–1273.
12. Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med 2009; 60:
39–54.
13. Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol 2004; 14: 70–77.
14. Shang J, Deguchi K, Yamashita T, Ohta Y, Zhang H, Morimoto N et al. Antiapoptotic and
antiautophagic effects of glial cell line-derived neurotrophic factor and hepatocyte growth
factor after transient middle cerebral artery occlusion in rats. J Neurosci Res 2010; 88:
2197–2206.
15. Chen W, Sun Y, Liu K, Sun X. Autophagy: a double-edged sword for neuronal survival after
cerebral ischemia. Neural Regen Res 2014; 9: 1210–1216.
16. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al.
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy
2012; 8: 445–544.
17. Sheng R, Liu XQ, Zhang LS, Gao B, Han R, Wu YQ et al. Autophagy regulates endoplasmic
reticulum stress in ischemic preconditioning. Autophagy 2012; 8: 310–325.
18. Rashid HO, Yadav RK, Kim HR, Chae HJ. ER stress: Autophagy induction, inhibition and
selection. Autophagy 2015; 11: 1956–1977.
19. van Walraven C, Austin P, Naylor CD. Vitamin B12 injections versus oral supplements. how
much money could be saved by switching from injections to pills? Can Fam Physician 2001;
47: 79–86.
20. Sinha RA, Farah BL, Singh BK, Siddique MM, Li Y, Wu Y et al. Caffeine stimulates hepatic
lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology 2014; 59:
1366–1380.
21. Zhou J, Tan SH, Nicolas V, Bauvy C, Yang ND, Zhang J et al. Activation of lysosomal function
in the course of autophagy via MTORC1 suppression and autophagosome-lysosome fusion.
Cell Res 2013; 23: 508–523.
22. Kalogeris T, Bao Y, Korthuis RJ. Mitochondrial reactive oxygen species: a double edged
sword in ischemia/reperfusion vs preconditioning. Redox Biol 2014; 2: 702–714.
23. Trush MA, Kensler TW. An overview of the relationship between oxidative stress and
chemical carcinogenesis. Free Radic Biol Med 1991; 10: 201–209.
24. Ashjazadeh N, Fathi M, Shariat A. Evaluation of homocysteine level as a risk factor among
patients with ischemic stroke and its subtypes. Iran J Med Sci 2013; 38: 233–239.
25. Hariri M, Maghsoudi Z, Darvishi L, Askari G, Hajishafiee M, Ghasemi S et al. B Vitamins and
antioxidants intake is negatively correlated with risk of stroke in Iran. Int J Prev Med 2013; 4
(Suppl 2): S284–S289.
26. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C. Homocysteine and
coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 2009;
30: 6–15.
27. Shi Z, Guan Y, Huo YR, Liu S, Zhang M, Lu H et al. Elevated total homocysteine l
evels in acute ischemic stroke are associated with long-term mortality. Stroke 2015; 46:
2419–2425.
28. Xu M, Zhang HL. Death and survival of neuronal and astrocytic cells in ischemic brain injury:
a role of autophagy. Acta Pharmacol Sin 2011; 32: 1089–1099.
29. Wang M, Ye R, Barron E, Baumeister P, Mao C, Luo S et al. Essential role of the unfolded
protein response regulator GRP78/BiP in protection from neuronal apoptosis. Cell Death
Differ 2010; 17: 488–498.
30. Tyagi N, Qipshidze N, Munjal C, Vacek JC, Metreveli N, Givvimani S et al.
Tetrahydrocurcumin ameliorates homocysteinylated cytochrome-c mediated autophagy in
hyperhomocysteinemia mice after cerebral ischemia. J Mol Neurosci 2012; 47: 128–138.
31. Kaizuka T, Hara T, Oshiro N, Kikkawa U, Yonezawa K, Takehana K et al. Tti1 and Tel2 are
critical factors in mammalian target of rapamycin complex assembly.. J Biol Chem 2010; 285:
20109–20116.
32. Lilienbaum A. Relationship between the proteasomal system and autophagy. Int J Biochem
Mol Biol 2013; 4: 1–26.
33. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S et al. A lysosome-to-nucleus
signalling mechanism senses and regulates the lysosome via MTOR and TFEB.
EMBO J 2012; 31: 1095–1108.
34. Carloni S, Girelli S, Scopa C, Buonocore G, Longini M, Balduini W. Activation of autophagy
and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in
neonatal hypoxia-ischemia. Autophagy 2010; 6: 366–377.
35. Sheng R, Zhang LS, Han R, Liu XQ, Gao B, Qin ZH. Autophagy activation is associated with
neuroprotection in a rat model of focal cerebral ischemic preconditioning. Autophagy 2010; 6:
482–494.
36. Lu Q, Harris VA, Kumar S, Mansour HM, Black SM. Autophagy in neonatal hypoxia ischemic
brain is associated with oxidative stress. Redox Biol 2015; 6: 516–523.
37. Troen AM, Lutgens E, Smith DE, Rosenberg IH, Selhub J. The atherogenic effect of excess
methionine intake. Proc Natl Acad Sci USA 2003; 100: 15089–15094.
38. Golde WT, Gollobin P, Rodriguez LL. A rapid, simple, and humane method for
submandibular bleeding of mice using a lancet. Lab Anim 2005; 34: 39–43.
39. Kovalevich J, Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in
neurobiology. Methods Mol Biol 2013; 1078: 9–21.
40. Yu M, Jiang Y, Feng Q, Ouyang Y, Gan J. DRAM1 protects neuroblastoma cells from
oxygen-glucose deprivation/reperfusion-induced injury via autophagy. Int J Mol Sci 2014; 15:
19253–19264.
41. Canazza A, Minati L, Boffano C, Parati E, Binks S. Experimental models of brain ischemia: a
review of techniques, magnetic resonance imaging, and investigational cell-based therapies.
Front Neurol 2014; 5: 19.
42. Kimura N, Kumamoto T, Kawamura Y, Himeno T, Nakamura KI, Ueyama H et al. Expression
of autophagy-associated genes in skeletal muscle: an experimental model of chloroquine-
induced myopathy. Pathobiology 2007; 74: 169–176.
43. Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B et al. The transcription
factor TFEB links MTORC1 signaling to transcriptional control of lysosome homeostasis.
Sci Signal 2012; 5: ra42.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution 4.0 International
License. The images or other third party material in this article are
included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from
the license holder to reproduce the material. To view a copy of this
license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2016
Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)
Vitamin B supplementation reverses ER stress caused by Hyperhomocysteinemia
M Tripathi et al
13
Cell Death and Disease
